Tag: valacyclovir

Lenacapavir Shows Viral Suppression in Drug-Resistant HIV

Dr Jean-Michel Molina The long-acting drug lenacapavir, a first-in-class capsid inhibitor, shows sustained viral suppression in a small cohort of heavily treatment-experienced patients with multidrug-resistant...

Three New Drugs Implicated in ANCA-Associated Vasculitis

The overactive bladder treatment mirabegron (Myrbetriq) is one of three new drugs to be linked to cases of drug-associated antineutrophil cytoplasmic antibody–associated vasculitis (DA-AAV) according...

Large Remdesivir Study Finds No COVID-19 Survival Benefit

Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. A lack of consensus in the evidence regarding the antiviral remdesivir (Veklury) to...

Hepatitis C Antivirals May Fight SARS-CoV-2

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. An antiviral drug combination used to treat hepatitis C and an...

Pandemic Boosts Care for Serious Illnesses at Home

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Late last year, Janet Yetenekian was one of the thousands of...

First Pill for COVID-19 Could Be Ready by Year’s End

New pills to treat patients with COVID-19 are currently in midstage clinical trials and, if successful, could be ready by the end of the year....

Oral Antiviral Stops SARS-CoV-2 in its Tracks

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A single pill of the investigational drug molnupiravir taken twice a...

FDA Says It Won’t Object to Dry Heat Use on N95 Respirators

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) says it will not...

Convalescent Plasma Falls Short in Phase 2 Trial

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Convalescent plasma may not prevent progression to severe disease or reduce...

FDA Approves Remdesivir, First Treatment for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) approved remdesivir (Veklury) today...

Remdesivir Does Not Reduce COVID-19 Mortality, Study Says

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A large study sponsored by the World Health Organization found that...

Two Major COVID Trials Paused for Safety Issues

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. This story was updated Oct. 13, at 4:05 p.m. Oct. 13,...

Once-Weekly Investigational MK-8507 Potent Even at Low Doses

A single dose of MK-8507, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), reduced HIV-1 viral loads for at least 1 week with efficacy comparable to...

Remdesivir Effective, Well-Tolerated in Final Trial Report

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A final report from the multinational placebo-controlled ACTT-1 trial confirms that...

Convalescent Blood Plasma Safe, Effective for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Convalescent blood plasma is a useful and relatively safe therapy for...

Trio Awarded Nobel Prize in Medicine for Discovering Hep C Virus

The Nobel Prize in Physiology or Medicine was awarded to two Americans and a British-born scientist this morning for the discovery of the hepatitis C...

The Art and Science of Risk Communication

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Infectious disease expert Anthony Fauci. Coronavirus response coordinator Deborah Birx. County...

COVID-19 Update: Elusive Complication, Remdesivir Toxicity

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

FDA OKs First-in-Class HIV Therapy for Patients With Few Options

The US Food and Drug Administration has approved fostemsavir (Rukobia, ViiV Healthcare), a first-in-class attachment inhibitor for the treatment of HIV-1 infection in adults. Fostemsavir...

Fauci Warns of 100K Cases/Day, HCQ Trial to Resume

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Prescription Fills Mostly Down for Leading Drugs

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Prescription fills for hydroxychloroquine/chloroquine spiked right after COVID-19 was declared a...

Fauci Testifies, HCQ Trials Lack ECG

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Triple Antiviral Combo May Speed COVID-19 Recovery

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. A triple-antiviral therapy regimen of interferon-beta1, lopinavir/ritonavir, and ribavirin shortened median...

What Are The Feds’ Plans for Distributing Remdesivir?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Following a week of uncertainty and calls for transparency regarding the...

Skin Manifestations, HCQ Heart Rhythm Risks

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...